Honigman represented Elucid Bioimaging Inc. in the transaction, and Latham and Watkins represented Elevage Medical Technologies.Elucid Bioimaging Inc. announced it has raised $80 million in Series C financing…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
